Table 2:
Defining alcohol associated hepatitis, modified from NIAAA AH clinical trial definition (Crabb et al Gastroenterology 2016)
| Definition | Clinical entity with rapid onset of jaundice with elevated AST in background of heavy alcohol use. |
| Pattern of alcohol use | Heavy alcohol use for >6 months, <60 days of abstinence before onset of jaundice. |
| Supporting features | |
| Biopsy | steatohepatitis, cholestasis, severe fibrosis |
| Presentation | malaise, tender hepatomegaly, decompensation |
| Labs | Br>3, AST/ALT ratio 1.5, AST<400 |
| Exclude | Drug induced liver injury, biliary obstruction, viral hepatitis, autoimmune liver disease, Wilson disease |
| Spectrum | AH versus acute on chronic liver failure Presence of cirrhosis |
| Definite | Clinical and biopsy proven |
| Probable | Clinical and exclude competing |
| Possible Biopsy recommended |
Clinically diagnosed but with potential confounding factors (e.g. pt denies alcohol) |
| Associated other diagnoses? | E.g. Viral hepatitis |